Opportunistic Salpingectomy in Non-Gynecologic Surgeries: Barriers and Facilitators From a Healthcare Provider Perspective

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-05-09 DOI:10.1002/cam4.70945
Charlotte Fisch, Tamar Gootzen, Joanne de Hullu, Philip de Reuver, Diederik Somford, Simon Nienhuijs, Jurgen Piek, Rosella Hermens
{"title":"Opportunistic Salpingectomy in Non-Gynecologic Surgeries: Barriers and Facilitators From a Healthcare Provider Perspective","authors":"Charlotte Fisch,&nbsp;Tamar Gootzen,&nbsp;Joanne de Hullu,&nbsp;Philip de Reuver,&nbsp;Diederik Somford,&nbsp;Simon Nienhuijs,&nbsp;Jurgen Piek,&nbsp;Rosella Hermens","doi":"10.1002/cam4.70945","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>This study identifies barriers and facilitators for implementing opportunistic salpingectomy (OS) during non-gynecological abdominal surgeries from a healthcare provider perspective.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>From October 2023 to July 2024, a mixed-method study was conducted. The qualitative phase involved semi-structured focus group interviews and individual interviews with specialists in surgery (gynecologists, general surgeons, urologists, and residents) and policymakers to identify barriers and facilitators for implementing OS during non-gynecological surgery. The quantitative phase consisted of a cross-sectional web-based survey assessing the importance of these barriers and facilitators. The study utilized the standardized implementation frameworks to categorize the factors into six domains: innovation, patient, healthcare professional, social setting, organization, and economic and financial context.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In the qualitative phase, 38 healthcare professionals and policymakers identified 38 barriers and 28 facilitators. Barriers were found in all domains and mainly included increased workload, unclear invoicing, and variations in eligible surgeries. Facilitators included the poor prognosis of ovarian cancer, simplicity of OS, and availability of counseling materials. The quantitative survey revealed that 75% of gynecologists, 60% of surgeons, and 61% of urologists supported offering OS during non-gynecological abdominal surgeries. Barriers identified included the ambiguity regarding which patients are eligible for OS, the perceived complication risks of OS, the increased workload as a result of adding OS, and the unclarity around invoicing an OS. Facilitators included the poor prognosis of ovarian cancer, the availability of uniform counseling materials, education on counseling and technical performance of OS, involvement of a gynecologist during the counseling, and clear agreements between the departments within hospitals.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Key barriers to OS implementation in non-gynecological surgeries include unclear invoicing and increased workload, while significant facilitators are the availability of counseling materials and education on counseling and technical performance of OS. Addressing these barriers and leveraging facilitators could enhance OS adoption, potentially reducing ovarian cancer incidence.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 9","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70945","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70945","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

This study identifies barriers and facilitators for implementing opportunistic salpingectomy (OS) during non-gynecological abdominal surgeries from a healthcare provider perspective.

Methods

From October 2023 to July 2024, a mixed-method study was conducted. The qualitative phase involved semi-structured focus group interviews and individual interviews with specialists in surgery (gynecologists, general surgeons, urologists, and residents) and policymakers to identify barriers and facilitators for implementing OS during non-gynecological surgery. The quantitative phase consisted of a cross-sectional web-based survey assessing the importance of these barriers and facilitators. The study utilized the standardized implementation frameworks to categorize the factors into six domains: innovation, patient, healthcare professional, social setting, organization, and economic and financial context.

Results

In the qualitative phase, 38 healthcare professionals and policymakers identified 38 barriers and 28 facilitators. Barriers were found in all domains and mainly included increased workload, unclear invoicing, and variations in eligible surgeries. Facilitators included the poor prognosis of ovarian cancer, simplicity of OS, and availability of counseling materials. The quantitative survey revealed that 75% of gynecologists, 60% of surgeons, and 61% of urologists supported offering OS during non-gynecological abdominal surgeries. Barriers identified included the ambiguity regarding which patients are eligible for OS, the perceived complication risks of OS, the increased workload as a result of adding OS, and the unclarity around invoicing an OS. Facilitators included the poor prognosis of ovarian cancer, the availability of uniform counseling materials, education on counseling and technical performance of OS, involvement of a gynecologist during the counseling, and clear agreements between the departments within hospitals.

Conclusions

Key barriers to OS implementation in non-gynecological surgeries include unclear invoicing and increased workload, while significant facilitators are the availability of counseling materials and education on counseling and technical performance of OS. Addressing these barriers and leveraging facilitators could enhance OS adoption, potentially reducing ovarian cancer incidence.

Abstract Image

机会性输卵管切除术在非妇科手术:障碍和促进从医疗保健提供者的角度
目的:本研究从医疗保健提供者的角度确定在非妇科腹部手术中实施机会性输卵管切除术(OS)的障碍和促进因素。方法于2023年10月~ 2024年7月采用混合方法进行研究。定性阶段包括半结构化的焦点小组访谈和与外科专家(妇科医生、普通外科医生、泌尿科医生和住院医生)和政策制定者的个人访谈,以确定在非妇科手术中实施OS的障碍和促进因素。定量阶段包括基于网络的横断面调查,评估这些障碍和促进因素的重要性。该研究利用标准化实施框架将这些因素分为六个领域:创新、患者、医疗保健专业人员、社会环境、组织以及经济和金融环境。结果在定性阶段,38名卫生保健专业人员和政策制定者确定了38个障碍和28个促进因素。在所有领域都发现了障碍,主要包括工作量增加、发票不清和合格手术的变化。促进因素包括卵巢癌预后不良、OS的简单性和咨询材料的可用性。定量调查显示,75%的妇科医生、60%的外科医生和61%的泌尿科医生支持在非妇科腹部手术中提供OS。确定的障碍包括哪些患者有资格接受手术,手术的并发症风险,增加手术的工作量增加,以及手术发票的不明确。促进因素包括卵巢癌预后不良、统一咨询材料的可用性、咨询教育和OS的技术性能、咨询过程中妇科医生的参与以及医院内各部门之间明确的协议。结论在非妇科手术中实施操作系统的主要障碍是发票不清和工作量增加,而重要的促进因素是咨询材料的可获得性以及对操作系统的咨询和技术性能的教育。解决这些障碍并利用促进者可以提高操作系统的采用,从而潜在地降低卵巢癌的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信